NCT07124494

Brief Summary

This is a single-center, prospective, randomized controlled trial aiming to evaluate the effects of different regional anesthesia/analgesia techniques on postoperative knee range of motion (ROM) and patient satisfaction following total knee arthroplasty (TKA). Ninety patients undergoing elective TKA under spinal anesthesia will be randomly assigned to one of three groups: 1) spinal anesthesia with epidural catheter, 2) spinal anesthesia followed by adductor canal catheterization, and 3) spinal anesthesia with multimodal intravenous analgesia. The primary outcome is postoperative knee joint ROM measured on postoperative days 1, 2, and 3. Secondary outcomes include patient satisfaction, Oxford Knee Score, postoperative opioid consumption, and VAS scores. The study is conducted at Konya City Hospital and will be completed over a 6-month period.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 5, 2025

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

August 8, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 15, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 12, 2026

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 19, 2026

Completed
Last Updated

August 28, 2025

Status Verified

August 1, 2025

Enrollment Period

6 months

First QC Date

August 8, 2025

Last Update Submit

August 21, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperative Knee Range of Motion (ROM)

    Knee joint flexion and extension range of motion will be measured using a standard goniometer by a blinded assessor. Measurements will be performed with the patient in a supine position, ensuring standardized positioning for all participants.

    Postoperative day 1, day 3, day 7, and day 90 after surgery.

Secondary Outcomes (5)

  • Total Opioid Consumption

    From the end of surgery to 72 hours postoperatively.

  • Oxford Knee Score (OKS)

    Preoperatively (baseline) and postoperative day 90.

  • Visual Analog Scale (VAS) Pain Score

    Postoperative day 1, day 3, and day 7 after surgery.

  • Incidence of Adverse Events Related to Anesthesia or Analgesia

    Intraoperative period and up to 90 days postoperatively.

  • Patient Satisfaction Score

    Postoperative day 3 and day 90 after surgery.

Study Arms (3)

Combined Spinal-Epidural Anesthesia

ACTIVE COMPARATOR

Postoperative analgesia will be provided via epidural catheter with programmed infusion of bupivacaine .

Procedure: Regional anethesia

Adductor Canal Block

ACTIVE COMPARATOR

Ultrasound-guided adductor canal catheter placement and continuous infusion of bupivacaine .

Procedure: Regional anethesia

Multimodal Intravenous Analgesia

SHAM COMPARATOR

Continuous intravenous tramadol infusion with rescue analgesia as required.

Procedure: Regional anethesia

Interventions

This single-center, prospective, randomized controlled trial aims to compare the effects of three different postoperative analgesia techniques following spinal anesthesia in patients undergoing total knee arthroplasty (TKA). The study will assess the impact of combined spinal-epidural anesthesia, adductor canal block, and multimodal intravenous analgesia on postoperative knee range of motion (ROM). Secondary outcomes include patient satisfaction, opioid consumption, Oxford Knee Score (OKS), activity levels, and visual analog scale (VAS) pain scores.

Adductor Canal BlockCombined Spinal-Epidural AnesthesiaMultimodal Intravenous Analgesia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Scheduled for primary total knee arthroplasty
  • Age ≥ 18 years
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Accepting neuraxial anesthesia

You may not qualify if:

  • Skin infection at the planned injection site
  • Sepsis
  • Coagulopathy
  • Refusal of neuraxial anesthesia
  • Severe hypovolemia
  • Demyelinating central nervous system disease
  • Age under 18 years
  • Illiterate in Turkish
  • Non-cooperative patients
  • Known allergy or hypersensitivity to bupivacaine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yasin Tire

Konya, Meram, 42140, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Pain, PostoperativePatient Satisfaction

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsTreatment Adherence and ComplianceHealth BehaviorBehavior

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof. Dr. Yasin Tire

Study Record Dates

First Submitted

August 8, 2025

First Posted

August 15, 2025

Study Start

August 5, 2025

Primary Completion

February 12, 2026

Study Completion

February 19, 2026

Last Updated

August 28, 2025

Record last verified: 2025-08

Locations